Melanoma, Skin cancer
Results
Phase 3
This trial looked at a new drug called trametinib (GSK1120212) for advanced melanoma. It was for people with a change in a gene called BRAF in their melanoma cells.
Recruitment start: 10 November 2010
Recruitment end: 16 May 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Nathan
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 08 Oct 2013
CRUK internal database number: 8174
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
